02.25.08: Biotechnology Report
A roundtable forum, 2 analysts and 18 sector firms examine the Biotechnology segment in this 92 page report from The Wall Street Transcript. Order this Report

  1. Roundtable Forum: Jennifer M. Chao, Deutsche Bank Securities Inc.; Dr. Jason Kantor, RBC Capital Markets; Dr.Thomas E. Shrader, Rodman & Renshaw, LLC

  2. Latest Developments in Biotechnology: Dr. Yaron Werber, Citi Investment Research

  3. Small & Micro-Cap Biotechnology Companies: Dr. George B. Zavoico, Cantor Fitzgerald

  4. CEO Interviews (average 2,500 words): Top management from 18 sector firms examine the outlook for their firm and sector. Firms interviewed include: Abaxis, Inc., Aeolus Pharmaceuticals, Inc., Bioanalytical Systems, Inc., BioSante Pharmaceuticals, Inc., Chemokine Therapeutics Corp., CytoGenix, Inc., GenVec, Inc., ImmuCell Corporation, Insmed Incorporated, Kythera Biopharmaceuticals, Inc., Luna Innovations Incorporated, Manhattan Pharmaceuticals, Inc., NBTY, Inc., Orexigen Therapeutics, Inc., PAREXEL International Corporation, SGX Pharmaceuticals, Inc., SONUS Pharmaceuticals, Inc., Telik, Inc.

    Topics covered: Positive clinical trials - Big Pharma partnerships & joint ventures - M&A activity - Financial market outlook - Premium drug candidate opportunities - FDA approval process - Restructuring of CDER and CBER divisions - Therapeutic antibodies segment - Oncology drug trials - HCV drugs - Research into neurology and Alzheimer’s - International diversification - Molecule drugs and diagnostics - Genetic engineering technologies - Drug discovery

    Companies covered: Genzyme (GENZ), Progenics (PGNX), Genentech (DNA), Amgen (AMGN) Biogen (BIIB), Celgene (CELG), Cubist Pharmaceuticals (CBST), Human Genome Sciences (HGSI), Gilead Sciences (GILD), MannKind (MNKD), InterMune (ITMN), Discovery Laboratories (DSCO), United Therapeutics (UTHR), AMAG Pharmaceuticals (AMAG), Tercica (TRCA), ISIS Pharmaceuticals (ISIS), Gilead Sciences (GILD), Celgene (CELG), Amylin Pharmaceuticals (AMLN), CV Therapeutics (CVTX), Genomic Health (GHDX), Cytokinetics (CYTK), Poniard Pharmaceuticals (PARD), Avalon Pharmaceuticals (AVRX).
    ORDER THIS REPORT NOW! CLICK HERE

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher

HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE